Your browser doesn't support javascript.
loading
Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects.
Takashima, Hiroki; Koga, Yoshikatsu; Tsumura, Ryo; Yasunaga, Masahiro; Tsuchiya, Masami; Inoue, Tadashi; Negishi, Eriko; Harada, Mitsunori; Yoshida, Sei; Matsumura, Yasuhiro.
Afiliação
  • Takashima H; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan; Innovation Center of NanoMedicine (iCONM), 3-25-14 Tono-machi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan.
  • Koga Y; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan; Innovation Center of NanoMedicine (iCONM), 3-25-14 Tono-machi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan.
  • Tsumura R; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
  • Yasunaga M; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan; Innovation Center of NanoMedicine (iCONM), 3-25-14 Tono-machi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan.
  • Tsuchiya M; Research Division, NanoCarrier Co., Ltd., 144-15 Chuo, 226-39 Wakashiba, Kashiwa, Chiba 277-0871, Japan.
  • Inoue T; Research Division, NanoCarrier Co., Ltd., 144-15 Chuo, 226-39 Wakashiba, Kashiwa, Chiba 277-0871, Japan.
  • Negishi E; Research Division, NanoCarrier Co., Ltd., 144-15 Chuo, 226-39 Wakashiba, Kashiwa, Chiba 277-0871, Japan.
  • Harada M; Research Division, NanoCarrier Co., Ltd., 144-15 Chuo, 226-39 Wakashiba, Kashiwa, Chiba 277-0871, Japan.
  • Yoshida S; Research Division, NanoCarrier Co., Ltd., 144-15 Chuo, 226-39 Wakashiba, Kashiwa, Chiba 277-0871, Japan.
  • Matsumura Y; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan; Innovation Center of NanoMedicine (iCONM), 3-25-14 Tono-machi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. Electronic add
J Control Release ; 323: 138-150, 2020 07 10.
Article em En | MEDLINE | ID: mdl-32259544
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Micelas / Antineoplásicos Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Micelas / Antineoplásicos Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão